Endocrine disruption of the epigenome: a breast cancer link
Open Access
- 14 February 2014
- journal article
- review article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 21 (2) , T33-T55
Abstract
The heritable component of breast cancer accounts for only a small proportion of total incidences. Environmental and lifestyle factors are therefore considered to among the major influencing components increasing breast cancer risk. Endocrine-disrupting chemicals (EDCs) are ubiquitous in the environment. The estrogenic property of EDCs has thus shown many associations between ongoing exposures and the development of endocrine-related diseases, including breast cancer. The environment consists of a heterogenous population of EDCs and despite many identified modes of action, including that of altering the epigenome, drawing definitive correlations regarding breast cancer has been a point of much discussion. In this review, we describe in detail well-characterized EDCs and their actions in the environment, their ability to disrupt mammary gland formation in animal and human experimental models and their associations with exposure and breast cancer risk. We also highlight the susceptibility of early-life exposure to each EDC to mediate epigenetic alterations, and where possible describe how these epigenome changes influence breast cancer risk.Keywords
This publication has 286 references indexed in Scilit:
- Endocrine Disruptors and the Breast: Early Life Effects and Later Life DiseaseJournal of Mammary Gland Biology and Neoplasia, 2013
- Activator-Induced Spread of Poly(ADP-Ribose) Polymerase Promotes Nucleosome Loss at Hsp70Molecular Cell, 2012
- Endocrine disrupting properties of perfluorooctanoic acidThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- DNA Demethylation DynamicsCell, 2011
- Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblastsMolecular and Cellular Endocrinology, 2010
- In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast CancerDiscover Oncology, 2010
- DNA methylation and methyl-CpG binding proteins: developmental requirements and functionChromosoma, 2009
- Polycyclic aromatic hydrocarbon–DNA adducts and survival among women with breast cancerEnvironmental Research, 2009
- Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanismsInternational Journal of Cancer, 2009
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009